EichorEICHOR
Location: Mitte Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Mitte

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · AbbVie · NCT06602479Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Phase 2 · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06722183Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Philip Morris Products S.A. · NCT07108166Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · AGO Study Group · NCT05009082A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Eli Lilly and Company · NCT07483099Endometrial Cancer Lymphadenectomy Trial
NA · Philipps University Marburg · NCT03438474A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598The Pancreatic Enzymes After Gastrectomy Trial
Phase 3 · University of Leipzig · NCT06058442International HIT-MED Registry (I-HIT-MED)
Phase N/A · Universitätsklinikum Hamburg-Eppendorf · NCT02417324Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Phase N/A · RECORDATI GROUP · NCT04176523PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · Women's Cancer Study Group GmbH · NCT05792150Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · Federation Francophone de Cancerologie Digestive · NCT07270991GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Goethe University · NCT02872987EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Daiichi Sankyo · NCT06330064Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor
Phase 2 · Merck Sharp & Dohme LLC · NCT04924075Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Ad
Phase 2 · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07176312Pan Tumor Rollover Study
Phase 2 · Bristol-Myers Squibb · NCT03899155A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · BioNTech SE · NCT07070232TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Phase N/A · NovoCure Ltd. · NCT05538806Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · University Hospital Freiburg · NCT06830421LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus
NA · Heinrich-Heine University, Duesseldorf · NCT05714930Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Phase N/A · Deutsches Herzzentrum der Charité · Biotronik SE & Co. KG · NCT04075084A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Phase 3 · Verastem, Inc. · NCT06072781Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Te
Phase 1/Phase 2 · Boehringer Ingelheim · NCT06324357Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Le
Phase 2 · Goethe University · NCT06648889
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.